Isabelli, Pasquale
(2025)
Design, development, and functional characterization of cold plasma systems to reduce airborbe transmission of hospital acquired infections & COVID-19, [Dissertation thesis], Alma Mater Studiorum Università di Bologna.
Dottorato di ricerca in
Scienze e tecnologie della salute, 37 Ciclo. DOI 10.48676/unibo/amsdottorato/11744.
Documenti full-text disponibili:
![Isabelli_Pasquale_tesi.pdf [thumbnail of Isabelli_Pasquale_tesi.pdf]](https://amsdottorato.unibo.it/style/images/fileicons/application_pdf.png) |
Documento PDF (English)
- Richiede un lettore di PDF come Xpdf o Adobe Acrobat Reader
Disponibile con Licenza: Salvo eventuali più ampie autorizzazioni dell'autore, la tesi può essere liberamente consultata e può essere effettuato il salvataggio e la stampa di una copia per fini strettamente personali di studio, di ricerca e di insegnamento, con espresso divieto di qualunque utilizzo direttamente o indirettamente commerciale. Ogni altro diritto sul materiale è riservato.
Download (6MB)
|
Abstract
This thesis investigates innovative strategies to improve indoor air quality, focusing on cold atmospheric plasma (CAP) as an alternative or complementary solution to traditional air treatment methods. The emergence of airborne diseases like COVID-19 and hospital acquired infections (HAIs) underscores the need for effective decontamination systems. CAP, which produces reactive species such as charged particles, radicals, and UV, has shown strong antimicrobial properties, particularly through reactive oxygen and nitrogen species (RONS) that inactivate microorganisms via multiple mechanisms. The dissertation is divided into three main sections. Chapter 1 presents a systematic review of CAP applications in virology, analyzing 110 studies published between 2000 and 2023. The review highlights CAP’s effectiveness in inactivating various viruses, including enveloped and non-enveloped, DNA and RNA types, through viral particle damage, replication disruption, and modulation of the host immune response. Chapter 2 regards the design and characterization of a direct dielectric barrier discharge (DBD) plasma source developed for decontaminating bacterial and viral bioaerosols. Serving as a proof of concept for the project, this device was among the first CAP prototypes to undergo biological testing against the SARS-CoV-2 virus. This prototype demonstrated a Log Reduction of 3.7 for bacterial bioaerosols and effectively inactivated SARS-CoV-2. Chapters 3, 4, and 5 describe the scaling-up of the proof-of-concept into two devices: the Rotating DBD, a tabletop unit for diverse environments (e.g. hospital rooms, offices, residential spaces), and the InDuct plasma source, designed for installation in ventilation ducts. Both devices were electrically characterized and their gas-phase chemistry was evaluated using various diagnostic techniques. They demonstrated over 99.9% efficacy in deactivating bacterial bioaerosols, including Staphylococcus epidermidis.
Abstract
This thesis investigates innovative strategies to improve indoor air quality, focusing on cold atmospheric plasma (CAP) as an alternative or complementary solution to traditional air treatment methods. The emergence of airborne diseases like COVID-19 and hospital acquired infections (HAIs) underscores the need for effective decontamination systems. CAP, which produces reactive species such as charged particles, radicals, and UV, has shown strong antimicrobial properties, particularly through reactive oxygen and nitrogen species (RONS) that inactivate microorganisms via multiple mechanisms. The dissertation is divided into three main sections. Chapter 1 presents a systematic review of CAP applications in virology, analyzing 110 studies published between 2000 and 2023. The review highlights CAP’s effectiveness in inactivating various viruses, including enveloped and non-enveloped, DNA and RNA types, through viral particle damage, replication disruption, and modulation of the host immune response. Chapter 2 regards the design and characterization of a direct dielectric barrier discharge (DBD) plasma source developed for decontaminating bacterial and viral bioaerosols. Serving as a proof of concept for the project, this device was among the first CAP prototypes to undergo biological testing against the SARS-CoV-2 virus. This prototype demonstrated a Log Reduction of 3.7 for bacterial bioaerosols and effectively inactivated SARS-CoV-2. Chapters 3, 4, and 5 describe the scaling-up of the proof-of-concept into two devices: the Rotating DBD, a tabletop unit for diverse environments (e.g. hospital rooms, offices, residential spaces), and the InDuct plasma source, designed for installation in ventilation ducts. Both devices were electrically characterized and their gas-phase chemistry was evaluated using various diagnostic techniques. They demonstrated over 99.9% efficacy in deactivating bacterial bioaerosols, including Staphylococcus epidermidis.
Tipologia del documento
Tesi di dottorato
Autore
Isabelli, Pasquale
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
37
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Cold plasma, airborne transmission, COVID-19,hospital acquired infections, bioaerosol
DOI
10.48676/unibo/amsdottorato/11744
Data di discussione
2 Aprile 2025
URI
Altri metadati
Tipologia del documento
Tesi di dottorato
Autore
Isabelli, Pasquale
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
37
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Cold plasma, airborne transmission, COVID-19,hospital acquired infections, bioaerosol
DOI
10.48676/unibo/amsdottorato/11744
Data di discussione
2 Aprile 2025
URI
Statistica sui download
Gestione del documento: